Archive for the ‘misconduct investigations’ Category
Catching up: OSU “missed fraud,” Dipak Das lost tenured professorship, Ivan on NPR’s Science Friday
We have a few follow-ups from stories we’ve recently covered:
Terry Elton case initially chalked up to “disorganization,” not misconduct
Ohio State University (OSU), which along with the Office of Research Integrity (ORI) recently sanctioned a pharmacy professor for image manipulation, “failed at first to recognize his deception,” according to an investigation by The Columbus Dispatch based on university documents.
The piece, which quotes Ivan, reveals that OSU needed some prompting from the ORI before it concluded that Terry Elton was guilty of misconduct, and not just unintentional errors that he at one point blamed on a research technician who lost her job in October 2011: Read the rest of this entry »
Stem cell retraction leaves grad student in limbo, reveals tangled web of industry-academic ties
A contested retraction in Stem Cells and Development has left the Queensland University of Technology (QUT) graduate student who fought for it in limbo, uncertain if he will earn his PhD. And many of those who didn’t want the paper retracted have a significant financial interest in a company whose work was promoted by the research — despite any lack of disclosure in the now-retracted paper.
Here’s the notice: Read the rest of this entry »
NUS: Melendez committed “serious scientific misconduct,” but don’t expect to get any details
Alirio Melendez, a former National University of Singapore immunologist whose story we’ve been following here since a retraction in September of last year, committed misconduct on an “unprecedented” scale, according to the university, involving more than 20 papers.
Nature’s Richard van Noorden has the scoop:
After a 19-month investigation, the National University of Singapore (NUS) today says that it has determined that one of its former scientists, the immunologist Alirio Melendez, has committed “serious scientific misconduct”. The university found fabrication, falsification or plagiarism associated with 21 papers, and no evidence indicating that other co-authors were involved in the misconduct, it says.
Melendez has retracted five papers so far, as we’ve reported, but NUS wouldn’t give the whole list. They tell Nature: Read the rest of this entry »
Concern — in triplicate — arrives for Poldermans papers
The Journal of the American College of Cardiology, or JACC, has issued expressions of concern for three papers by Don Poldermans, the Dutch cardiologist who was fired earlier this year amid allegations of misconduct.
Cardiobrief’s Larry Husten had the story first.
The, um, heart of the matter is that neither the investigators at Erasmus Medical Center, Poldermans’ former institution, nor the JACC editors, can say whether the researchers conduct rose to the level of fabricating data. As the Notice of Concern states: Read the rest of this entry »
Dental papers retracted after investigations find “issue with respect to misconduct”
Sometimes, retraction notices offer tantalizing clues, but no real information. Take the case of a paper called “Florid osseous dysplasia,” which was published last year in Journal of Oral and Maxillofacial Pathology by a group at Mumbai’s Nair Hospital Dental College and retracted recently.
Here’s the notice, which is suggestive but doesn’t say much: Read the rest of this entry »
Funding agency sanctions Bulfone-Paus and former postdoc
Retraction Watch readers may recall the case of Silvia Bulfone-Paus, a researcher at Germany’s Research Center Borstel who was a frequent subject of posts in the early days of this blog. Bulfone-Paus has had to retract 13 papers amid investigations into allegations of image manipulation.
To briefly recap: In May 2010, several months after concerns had first been raised, Borstel let the DFG (German Research Foundation) know about the allegations, because they had funded the work. A November 2010 report from Borstel said that the allegations had merit, blaming two of Bulfone-Paus’s postdocs but criticizing how she supervised them. As the DFG notes in a summary of its findings on the case, posted late last week: Read the rest of this entry »
Two patch-clamping retractions in PNAS and the JCI after first author admits image manipulation
A group of cardiology researchers formerly of the University of Cologne has retracted two papers, after investigations into allegations of misconduct led to an admission of guilt by one of the lab’s junior members.
Here’s the first retraction, for “Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes,” published last week in the Journal of Clinical Investigation: Read the rest of this entry »
Going Dutch: Stapel inquiry eyes credulous colleagues, institution, prompts national soul search
Dutch investigators have released their final report into the case of Diederik Stapel, the social scientist and erstwhile faculty member at Tilburg University who fabricated data in 55 articles and book chapters. So far, 31 of Stapel’s published papers have been retracted — three others have expressions of concern — although more might follow.
In addition, 10 dissertations by students Stapel supervised were found to contain fraudulent data, although those students were cleared of any wrongdoing in the inquiry.
The report — and we’re going by rough translations here — found that Stapel’s colleagues and administrators seemed to accept his results at face value. Meanwhile, his high profile at Tilburg insulated him against initial rumblings about problems with his data. As the Dutch paper NRC Handelsblad reported: Read the rest of this entry »



